|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Quality Standards Compliance for Mammography FacilitiesBy October 1, 1994, all U.S. mammography facilities, except those managed by the Department of Veterans Affairs, must be certified by the Food and Drug Administration (FDA) to legally continue to provide mammography services. The requirement is a result of the Mammography Quality Standards Act of 1992 (MQSA), which requires national, uniform quality standards for mammography facilities* and is intended to ensure that all women have access to safe and effective mammography services for early detection of breast cancer. The law requires that:
FDA was delegated the authority to implement MQSA in June 1993. On December 21, 1993, FDA published interim standards in the Federal Register covering equipment, personnel, quality assurance, and recordkeeping and reporting (1). The interim standards also set requirements that must be met by accrediting bodies. FDA is collaborating with the National Mammography Quality Assurance Advisory Committee to develop more comprehensive, final standards. The accrediting bodies will provide FDA with the names and addresses of the facilities they have accredited. FDA will then issue certificates to all accredited facilities. FDA is also providing a series of training courses for federal and state inspectors, who must pass three written and two practical proficiency examinations before conducting inspections. Facilities will be subject to MQSA inspections as of October 1. The MQSA program combines the elements of the ACR's voluntary Mammography Accreditation Program and the Medicare Screening Mammography Benefit program of the Health Care Financing Administration (HCFA). After October 1, HCFA will accept FDA certification as the basis for Medicare reimbursement, and HCFA inspections will cease. Additional information about the MQSA program and subscriptions for FDA's quarterly newsletter, Mammography Matters, is available by calling (301) 443-4190; fax (301) 594-3306. Reported by: Div of Mammography Quality and Radiation Programs, Office of Health and Industry Programs, Center for Devices and Radiological Health, Food and Drug Administration. Reference
* Public Law 102-539 Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|